Directory
>
David Bleakman
David Bleakman
President Drug Discovery and Development | PsychoGenics
United States
David Bleakman
Summary
David Bleakman, PhD, is a seasoned executive in the biological products industry, currently serving as President of Drug Discovery and Development at Psychogenics. With extensive experience in neuroscience and drug development, he has held various leadership roles at Eli Lilly, where he led neuroscience initiatives and contributed to multiple successful drug discoveries. David has also shared his expertise as an adjunct professor at the Icahn School of Medicine at Mount Sinai. His academic credentials include a PhD from King's College London and a post-doctoral fellowship at The University of Chicago. Known for his innovative approach, he is passionate about advancing therapeutic options in the fields of psychiatry and neurology. David's career reflects a commitment to bridging scientific research with practical applications in the pharmaceutical industry.
David Bleakman
Work Experience
President Drug Discovery and Development at
PsychoGenics
June 2022 - Present
Adjunct Professor at
Department Of Neuroscience Icahn School Of Medicine At Mount Sinai
January 2018 - Present
Chief Scientific Officer at
Redpin Therapeutics
August 2018 - March 2023
Honorary Visiting Professor, School of Physiology, Pharmacology, and Neuroscience at
University Of Bristol
January 2016 - June 2019
Vice President, CSO, Neuroscience Site Leader, New York at
Eli Lilly and Company
December 2016 - February 2018
Executive Director, Neuroscience CSO and Lilly Neuroscience Site Leader, New York at
Eli Lilly and Company
June 2014 - November 2016
Executive Director and CSO, Psychiatric Disorders Research at
Eli Lilly and Company
May 2008 - May 2014
Executive Director and CSO, Pain/Migraine Reserach and Psychiatric Disorders Research at
Eli Lilly and Company
May 2007 - April 2008
CSO Pain/Migraine Research at
Eli Lilly and Company
October 2004 - April 2007
Director, Neuroscience Division at
Eli Lilly and Company
June 2001 - October 2004
Senior Research Scientist at
Eli Lilly and Company
January 2000 - May 2001
Research Scientist at
Eli Lilly and Company
August 1997 - December 1999
Research Scientist at
Eli Lilly and Company
January 1997 - July 1997
Senior Biologist at
Eli Lilly and Company
January 1995 - December 1996
Principal Biologist at
Eli Lilly and Company
February 1993 - December 1994
David Bleakman
Education
January 1989 - January 1993
King's College London, Doctor Of Philosophy - Phd
Frequently Asked Questions about David Bleakman
What is David Bleakman email address?
David Bleakman's primary email address is *****@bristol.ac.uk. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Bleakman work for?
David Bleakman is a President Drug Discovery and Development at PsychoGenics, a company specializing in Scientific Research & Development Services.
Where David Bleakman graduated from?
David Bleakman holds a degree in Post-Doctoral Fellow from The University of Chicago.
How can I directly contact David Bleakman?
To contact David Bleakman directly, you can use the email address *****@bristol.ac.uk. Complete contact information is available upon registration with Muraena.
Who is David Bleakman?
David Bleakman, PhD, is a seasoned executive in the biological products industry, currently serving as President of Drug Discovery and Development at Psychogenics. With extensive experience in neuroscience and drug development, he has held various leadership roles at Eli Lilly, where he led neuroscience initiatives and contributed to multiple successful drug discoveries. David has also shared his expertise as an adjunct professor at the Icahn School of Medicine at Mount Sinai. His academic credentials include a PhD from King's College London and a post-doctoral fellowship at The University of Chicago. Known for his innovative approach, he is passionate about advancing therapeutic options in the fields of psychiatry and neurology. David's career reflects a commitment to bridging scientific research with practical applications in the pharmaceutical industry.
David`s contact details
*****@bristol.ac.uk
**************@psychogenics.com
Colleagues
Senior Vice President, Neurodegenerative Disorders
Co Founder And Volunteer
Vice President, Head of Medicinal Chemistry, Drug Discovery
VP, Translational Neuroscience
Chief Technology Officer
Vice President Human Resources
Vice President Quality Assurance & Regulatory Affairs
Research Scientist, Director DLAR
Vice President